EG vs STRO
Everest Group Ltd (EG) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
EG currently screens at market cap $14.52B and trailing P/E 17.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the EG and STRO stock pages for the full models.
Not investment advice.